Overall, data support that the triplication of genes encoded on HSA21 (e.g., BACH1) is involved in the appearance of detrimental conditions, such as increased OS, that over time might contributes to the early development of AD pathology in individuals with DS. This evidence concerns the gene BACH1 and Dravet syndrome.